The number of CD45/CD18-single-positive cells in the patients with CRS was 3–6 times as high as that in the control patients, while the reverse trend emerged for the CD45/CD18–vimentin-double-positive cells (Table 4). The gene discussed is ITGB2; the disease is congenital rubella syndrome.